Parametric Portfolio Associates’s NxStage Medical Inc. NXTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-25,712
Closed -$736K 4009
2018
Q4
$736K Sell
25,712
-1,860
-7% -$52.8K ﹤0.01% 3139
2018
Q3
$769K Buy
27,572
+1,234
+5% +$34.7K ﹤0.01% 3231
2018
Q2
$735K Buy
26,338
+434
+2% +$11.6K ﹤0.01% 3192
2018
Q1
$644K Buy
25,904
+8,283
+47% +$201K ﹤0.01% 3223
2017
Q4
$427K Sell
17,621
-28,306
-62% -$746K ﹤0.01% 3415
2017
Q3
$1.27M Sell
45,927
-15,115
-25% -$403K ﹤0.01% 2891
2017
Q2
$1.53M Buy
61,042
+15,326
+34% +$379K ﹤0.01% 2715
2017
Q1
$1.23M Buy
45,716
+14,384
+46% +$397K ﹤0.01% 2748
2016
Q4
$821K Sell
31,332
-1,421
-4% -$35.1K ﹤0.01% 2946
2016
Q3
$818K Sell
32,753
-13,140
-29% -$306K ﹤0.01% 2922
2016
Q2
$995K Sell
45,893
-846
-2% -$15.1K ﹤0.01% 2834
2016
Q1
$701K Buy
46,739
+582
+1% +$9.75K ﹤0.01% 3150
2015
Q4
$1.01M Buy
46,157
+5,362
+13% +$99.9K ﹤0.01% 2761
2015
Q3
$643K Buy
40,795
+3,790
+10% +$60.8K ﹤0.01% 2589
2015
Q2
$529K Sell
37,005
-13,810
-27% -$234K ﹤0.01% 3240
2015
Q1
$879K Buy
50,815
+10,784
+27% +$191K ﹤0.01% 2884
2014
Q4
$718K Buy
40,031
+13,250
+49% +$213K ﹤0.01% 3036
2014
Q3
$352K Buy
26,781
+953
+4% +$12.8K ﹤0.01% 3400
2014
Q2
$371K Buy
25,828
+370
+1% +$4.83K ﹤0.01% 3400
2014
Q1
$324K Buy
25,458
+625
+3% +$8.15K ﹤0.01% 3408
2013
Q4
$248K Sell
24,833
-7,227
-23% -$82K ﹤0.01% 3517
2013
Q3
$422K Buy
32,060
+739
+2% +$9.69K ﹤0.01% 3199
2013
Q2
$447K Buy
+31,321
New +$394K ﹤0.01% 3061

Other funds holding NXTM

Parametric Portfolio Associates's NXTM Position: Q1 2019 in Review

Parametric Portfolio Associates sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 25,712 shares — an estimated $736K sold.

Parametric Portfolio Associates first reported a position in NXTM in Q2 2013 and held it in 23 quarters. The position peaked at $1.53M in Q2 2017. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • Parametric Portfolio Associates reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • Parametric Portfolio Associates sold 25,712 NxStage Medical Inc. shares in Q1 2019, an estimated $736K.
  • Parametric Portfolio Associates first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 23 quarters.
  • Parametric Portfolio Associates's NxStage Medical Inc. position peaked at $1.53M in Q2 2017.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Parametric Portfolio Associates's 13F filing for Q1 2019, filed 9 May 2019.